Streetbeat News

FIGS

FIGS, Inc.

https://www.wearfigs.com

Industry

Apparel - Manufacturers

FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States. It designs and sells healthcare apparel and other non-scrub offerings, such as lab coats, under scrubs, outerwear, activewear, loungewear, compression socks footwear, and masks. It also offers sports bras, performance leggings, tops, super-soft pima cotton tops, vests, and jackets. The company markets and sells its products through its digital platform comprising website and mobile app. FIGS, Inc. was founded in 2013 and is headquartered in Santa Monica, California.

Open

4.66

Mkt cap

752M

Volume

1.6M

High

4.70

P/E Ratio

231.50

52-wk high

7.05

Low

4.60

Div yield

N/A

52-wk low

4.30

Figs, Inc. is considered undervalued with potential for significant returns due to strong private equity interest and a robust balance sheet. Favorable growth trends in healthcare employment and broader market appeal support optimistic revenue projections, suggesting a 25% upside from the current share price.

Portfolio Pulse from

March 06, 2025 | 8:15 am

FIGS, Inc. faces challenges with declining U.S. sales and weak FY25 guidance, despite strong international growth. High marketing costs and poor customer acquisition raise concerns about profitability, making its high valuation questionable.

Portfolio Pulse from

March 04, 2025 | 5:30 pm

FIGS, Inc. held its Q4 2024 earnings call, discussing financial results and company performance. Key participants included executives and analysts from major financial institutions.

Portfolio Pulse from

February 28, 2025 | 12:45 am

Figs (FIGS) reported its Q4 earnings, focusing on revenue and EPS. Investors should consider how these metrics compare to Wall Street estimates and the previous year's figures.

Portfolio Pulse from

February 28, 2025 | 12:45 am

Figs (FIGS) reported Q4 earnings of $0.01 per share, meeting the Zacks Consensus Estimate but down from $0.05 per share a year ago.

Portfolio Pulse from

February 28, 2025 | 12:00 am

Figs (FIGS) is approaching its Q4 earnings release, with analysts focusing on more than just revenue and EPS. Key metrics are being evaluated to understand the company's performance for the quarter ending December 2024.

Portfolio Pulse from

February 26, 2025 | 3:30 pm

Figs, a scrubs maker, has rejected a take-private acquisition offer from private equity firm Story3 Capital Partners.

Portfolio Pulse from

January 16, 2025 | 10:00 pm

Applied Fundamental Research, a shareholder of FIGS, Inc., has issued an open letter to the company's management and Board of Directors. The letter praises FIGS' achievements in the healthcare apparel market and suggests a clear capital allocation strategy to enhance shareholder value.

Portfolio Pulse from

December 20, 2024 | 7:15 pm

FIGS, a company with strong free cash flow and no debt, has received a $6 per share offer from Story3 Capital to take it private. This offer is seen as undervaluing the company, which has seen its stock drop from over $35 to $6.07 since its IPO.

Portfolio Pulse from

December 16, 2024 | 9:00 am

Medical-apparel maker Figs has received a takeover bid from private-equity firm Story3, valuing the company at over $1 billion.

Portfolio Pulse from

December 10, 2024 | 10:45 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.